JNNP

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

Journal of Neurology, Neurosurgery, and Psychiatry 2006;77:579-584; doi:10.1136/jnnp.2005.075929
Copyright © 2006 by the BMJ Publishing Group Ltd.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Web-only appendix
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sockeel, P
Right arrow Articles by Defebvre, L
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sockeel, P
Right arrow Articles by Defebvre, L
Related Collections
Right arrow Parkinson's disease

PAPER

The Lille apathy rating scale (LARS), a new instrument for detecting and quantifying apathy: validation in Parkinson’s disease

P Sockeel1, K Dujardin1, D Devos2, C Denève2, A Destée2, L Defebvre2

1 Psychology Department, Charles De Gaulle University, Lille, France
2 Neurology and Movement Disorders Unit, EA2683, Faculty of Medicine and Lille University Hospital, Lille

Correspondence to:
Correspondence to:
Dr Pascal Sockeel
UFR de Psychologie, BP 149, F-59653 Villeneuve D’Ascq cedex, France; pascal.sockeel{at}univ-lille3.fr

Background: Apathy is usually defined as reduced interest and participation in various activities. It is a frequent consequence of neurological and psychiatric disorders. Although various scoring methods have been proposed, there is a lack of validated, standardised instruments for detecting apathy and assessing its severity.

Objective: To develop an apathy rating scale using a structured standardised interview capable of distinguishing between the condition’s various features.

Methods: The Lille Apathy Rating Scale (LARS) is based on a structured interview. It includes 33 items, divided into nine domains. Responses are scored on a dichotomous scale. The participants used to validate the scale consisted of 159 patients with probable Parkinson’s disease and 58 healthy control subjects. The Marin Apathy Scale, the Montgomery and Asberg Depression Rating Scale, and the Mattis Dementia Rating Scale were also administered.

Results: Principal component analysis showed that the LARS probed a single construct which forms the root of an oblique factor structure reflecting four dimensions: intellectual curiosity, self awareness, emotion, and action initiation. The main psychometric properties of the LARS (internal consistency, inter-rater and test-retest reliability) were satisfactory. Concurrent validity was evaluated by reference to the Marin scale and to judgements provided by expert clinicians.

Conclusions: Standard validity indices showed that the LARS is sensitive and capable of distinguishing between apathy and depression. As a screening tool, the scale is able to support dichotomous judgements accurately and, when greater measurement sensitivity is required, also determine the severity of apathy within a four category classification.


Abbreviations: AES, apathy evaluation scale; DRS, dementia rating scale; LARS, Lille Apathy Rating Scale; MADRS, Montgomery and Asberg depression rating scale; NPI, Neuropsychiatric Inventory; UPDRS, Unified Parkinson’s Disease Rating Scale

Keywords: apathy; Parkinson’s disease




This article has been cited by other articles:


Home page
J. Neurol. Neurosurg. PsychiatryHome page
D Devos, P Krystkowiak, F Clement, K Dujardin, O Cottencin, N Waucquier, K Ajebbar, B Thielemans, M Kroumova, A Duhamel, et al.
Improvement of gait by chronic, high doses of methylphenidate in patients with advanced Parkinson's disease
J. Neurol. Neurosurg. Psychiatry, May 1, 2007; 78(5): 470 - 475.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2006 by the BMJ Publishing Group Ltd.